Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer. | BMC Cancer | 2022 | 35907803 | PubTator, text mining | PubMed |
| The Long Non-Coding Antisense RNA JHDM1D-AS1 Regulates Inflammatory Responses in Human Monocytes. | Front Cell Infect Microbiol | 2022 | 35903199 | PubTator, text mining | PubMed |
| IL-36 Cytokines: Their Roles in Asthma and Potential as a Therapeutic. | Front Immunol | 2022 | 35903102 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. | Cell Rep Med | 2022 | 35896115 | PubTator, text mining | PubMed |
| Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease. | Noncoding RNA | 2022 | 35893239 | PubTator, text mining | PubMed |
| Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing. | Cancers (Basel) | 2022 | 35892844 | PubTator, text mining | PubMed |
| Genomic Divergence Characterization and Quantitative Proteomics Exploration of Type 4 Porcine Astrovirus. | Viruses | 2022 | 35891364 | PubTator, text mining | PubMed |
| Reprogramming Metabolism of Macrophages as a Target for Kidney Dysfunction Treatment in Autoimmune Diseases. | Int J Mol Sci | 2022 | 35887371 | PubTator, text mining | PubMed |
| Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis. | Biomedicines | 2022 | 35884999 | PubTator, text mining | PubMed |
| A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer. | Cancers (Basel) | 2022 | 35884498 | PubTator, text mining | PubMed |
| CXCR2 Is Essential for Radiation-Induced Intestinal Injury by Initiating Neutrophil Infiltration. | J Immunol Res | 2022 | 35879949 | PubTator, text mining | PubMed |
| Phenotypic and Transcriptomics Analyses Reveal Underlying Mechanisms in a Mouse Model of Corneal Bee Sting. | Toxins (Basel) | 2022 | 35878206 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Unravels Distinct Tumor Microenvironment of Different Components of Lung Adenocarcinoma Featured as Mixed Ground-Glass Opacity. | Front Immunol | 2022 | 35874770 | PubTator, text mining | PubMed |
| Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities. | J Immunother Cancer | 2022 | 35863823 | PubTator, text mining | PubMed |
| Eicosanoid-Activated PPARα Inhibits NFκB-Dependent Bacterial Clearance During Post-Influenza Superinfection. | Front Cell Infect Microbiol | 2022 | 35860381 | PubTator, text mining | PubMed |
| Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration. | Aging (Albany NY) | 2022 | 35859293 | PubTator, text mining | PubMed |
| FOXM1 network in association with TREM1 suppression regulates NET formation in diabetic foot ulcers. | EMBO Rep | 2022 | 35856334 | PubTator, text mining | PubMed |
| A 16-miRNA Prognostic Model to Predict Overall Survival in Neuroblastoma. | Front Genet | 2022 | 35846139 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma. | Comput Math Methods Med | 2022 | 35844446 | PubTator, text mining | PubMed |
| Innate immunity to SARS-CoV-2 infection: a review. | Epidemiol Infect | 2022 | 35843719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=50